CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beihai Gofar Chuanshan Biological Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beihai Gofar Chuanshan Biological Co Ltd
No.3, Beibuwan Middle Road
Phone: +86 7793200619p:+86 7793200619 BEIHAI, GUX  536000  China Ticker: 600538600538
Business Summary
Beihai Gofar Chuanshan Biological Co Ltd is a China-based company mainly engaged in the wholesale and retail of various drugs and medical devices. The Company primarily operates its businesses through four segments. The Pharmaceutical Distribution segment is mainly engaged in wholesale and retail of drugs. The Pharmaceutical Manufacturing segment mainly produces and sells traditional Chinese patent medicines and simple preparations such as Pearl Eye Drops. The Deoxyribonucleic Acid (DNA) Identification and Service segment is mainly engaged in the production and sales of judicial DNA testing equipment and reagent consumables, as well as providing technical services such as DNA testing services. Other segment is mainly engaged in medical imaging centers and sales of medical devices.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024Yes----

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
5912 Drug stores and proprietary stores
5047 Medical, dental, and hospital equipment and supplies
2835 In vitro and in vivo diagnostic substances
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8071 Medical laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board FangcaiCheng 38 12/25/2025 12/25/2025
President, Director XiaoweiZhang 45 4/18/2025 1/21/2025
Chief Financial Officer, Vice President, Director ZhiboYin 47 9/3/2010 9/3/2010
7 additional Officers and Directors records available in full report.

Business Names
Business Name
600538
Beihai Gofar Marine Biological Industry

General Information
Number of Employees: 453 (As of 12/31/2024)
Outstanding Shares: 524,198,348 (As of 9/30/2025)
Shareholders: 20,978
Stock Exchange: SHA
Fax Number: +86 7793200618


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 12, 2026